Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)

PHASE2CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

March 31, 2014

Study Completion Date

December 31, 2014

Conditions
Severe Traumatic Brain Injury
Interventions
DEVICE

Management protocol based on pBrO2 and ICP values.

For patients who experience falls in pBrO2 below 20 mm Hg, a hierarchical treatment algorithm will be instituted, adapted from published recommendations49. In principle, episodes requiring therapy will fall into one of 4 scenarios (scenario A, B, C, and D, defined in figure 7), which will require different management strategies. The treatment protocol depends on which type of episode is being treated. Treatment is triggered by abnormalities in either ICP (\> 20 mm Hg) or pBrO2 (\< 20 mm Hg) are noted. Elevations in ICP above 20 mm Hg or decline in pBrO2 below 20 mm Hg for more than 5 minutes will trigger a treatment intervention. Treatment is directed to an episode. Patients may start in one type of episode and move to another. Therapy will depend on which type of episode they are in at any given time.

DEVICE

Management protocol based on ICP values only.

For the patients randomized to ICP treatment alone, only Scenario A and Scenario B episodes are relevant.

Trial Locations (10)

19107

University of Pennsylvania, Philadelphia

27710

Duke University, Durham

33136

University of Miami/Jackson Memorial Hospital, Miami

75390

University of Texas Southwestern Medical Center, Dallas

98104

University of Washington/Harborview Medical Center, Seattle

Unknown

University of Cincinnati, Cincinnati

Ohio State University, Columbus

Temple University, Philadelphia

Thomas Jefferson University, Philadelphia

University of Pittsburgh, Pittsburgh

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Washington

OTHER

collaborator

University of Miami

OTHER

collaborator

University of Pittsburgh

OTHER

collaborator

Duke University

OTHER

collaborator

Ohio State University

OTHER

collaborator

Temple University

OTHER

collaborator

Thomas Jefferson University

OTHER

collaborator

University of Cincinnati

OTHER

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Pennsylvania

OTHER